dityrosine has been researched along with Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amstrup, SK; Bjerrum, MJ; Christiansen, G; Costeira-Paulo, J; Davies, MJ; Grønnemose, AL; Ilag, LL; Jørgensen, TJD; Landreh, M; Marklund, EG; Møller, IM; Nielsen, J; Österlund, N; Otzen, DE; Pedersen, JN; Pedersen, JS; Rao, RSP; Sahin, C; Tiwari, MK; Østerlund, EC | 1 |
| Belsom, A; Bieschke, J; Binolfi, A; Rappsilber, J; Selenko, P; Shah, M; Theillet, FX; Verzini, S; Wanker, EE | 1 |
| Abdul-Sada, A; Al-Hilaly, YK; Biasetti, L; Blakeman, BJ; Pollack, SJ; Serpell, LC; Thorpe, JR; Xue, WF; Zibaee, S | 1 |
| Biere, AL; Carpenter, JF; Chi, EY; Citron, M; Garzon-Rodriguez, W; Kendrick, BS; Krishnan, S; Li, C; Narhi, LO; Randolph, TW; Wood, SJ; Wypych, J | 1 |
| Kang, JH; Kim, KS | 1 |
| Heinecke, JW; Jackson-Lewis, V; Pennathur, S; Przedborski, S | 1 |
6 other study(ies) available for dityrosine and Parkinson Disease
| Article | Year |
|---|---|
Structural Basis for Dityrosine-Mediated Inhibition of α-Synuclein Fibrillization.
Topics: alpha-Synuclein; Amyloid; Humans; Parkinson Disease; Tyrosine | 2022 |
Megadalton-sized Dityrosine Aggregates of α-Synuclein Retain High Degrees of Structural Disorder and Internal Dynamics.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Peptides; Cytochromes c; Humans; Magnetic Resonance Spectroscopy; Mitochondria; Neurons; Oxidative Stress; Parkinson Disease; Protein Aggregates; Protein Conformation; Reactive Oxygen Species; Tyrosine | 2020 |
The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Amino Acid Sequence; Brain; Copper; Dimerization; Electrophoresis, Polyacrylamide Gel; Humans; Lewy Bodies; Male; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Recombinant Proteins; Tandem Mass Spectrometry; Tyrosine | 2016 |
Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis.
Topics: alpha-Synuclein; Amino Acid Substitution; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Dimerization; Humans; Hydrogen-Ion Concentration; Light; Nerve Tissue Proteins; Osmolar Concentration; Osmotic Pressure; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Protein Isoforms; Scattering, Radiation; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry, Ultraviolet; Synucleins; Temperature; Tyrosine | 2003 |
Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Topics: alpha-Synuclein; Amino Acid Substitution; Anserine; Antioxidants; Antiparkinson Agents; Biopolymers; Carnosine; Chelating Agents; Codon; Copper; Edetic Acid; Free Radical Scavengers; Humans; Hydrogen Peroxide; Hydroxyl Radical; Isopropyl Thiogalactoside; Lewy Bodies; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Phenylmethylsulfonyl Fluoride; Point Mutation; Resins, Synthetic; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1; Synucleins; Tyrosine | 2003 |
Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Brain; Chelating Agents; Dopamine Agents; Free Radicals; Gas Chromatography-Mass Spectrometry; Male; Mice; Mice, Inbred C57BL; Nitrates; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Pentetic Acid; Tissue Distribution; Tyrosine | 1999 |